Revision history of "CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model" (Q85010396)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 May 2024

  • curprev 18:5318:53, 23 May 2024 Emijrpbot talk contribs 47,714 bytes +4,655 Changed label, description and/or aliases in 55 languages: BOT - Adding descriptions (55 languages): ar, bg, bn, ca, cs, da, de, el, eo, es, et, fa, fi, fr, gl, he, hu, it, ja, ka, ko, lt, nan, nb, nn, oc, pl, pt, pt-br, ro, ru, sk, sq, sr, sr-ec, sr-el, sv, tg, tg-cyrl, th, tl, tr, ur, vi, wuu, yue, zh, zh-cn, zh-hans, zh-hant, zh-hk, zh-mo, zh-my, zh-sg, zh-tw undo

19 November 2022

23 October 2022

4 August 2022

2 May 2022

15 February 2022

26 July 2020

23 July 2020

16 July 2020

13 February 2020